Buscar
OrthoPediatrics Corp
KIDSAñadir a la lista de seguimiento
19.950USD
+0.650+3.37%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
510.82MCap. mercado
PérdidaP/E TTM
Más Datos de OrthoPediatrics Corp Compañía
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
Información de OrthoPediatrics Corp
Símbolo de cotizaciónKIDS
Nombre de la empresaOrthoPediatrics Corp
Fecha de salida a bolsaOct 12, 2017
Director ejecutivoBailey (David R)
Número de empleados562
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 12
Dirección2850 Frontier Drive
CiudadWARSAW
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal46582
Teléfono15742686379
Sitio Webhttps://www.orthopediatrics.com/
Símbolo de cotizaciónKIDS
Fecha de salida a bolsaOct 12, 2017
Director ejecutivoBailey (David R)
Ejecutivos de OrthoPediatrics Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David R. Bailey
Mr. David R. Bailey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
417.16K
+28.56%
Mr. Fred L. Hite
Mr. Fred L. Hite
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
277.48K
--
Mr. Mark C. Throdahl
Mr. Mark C. Throdahl
Chairman of the Board
Chairman of the Board
201.81K
+5.67%
Mr. Joseph W. Hauser
Mr. Joseph W. Hauser
President of Trauma, Deformity and OPSB
President of Trauma, Deformity and OPSB
194.77K
--
Mr. Gregory A. Odle
Mr. Gregory A. Odle
President of Scoliosis
President of Scoliosis
187.74K
--
Mr. David R. Pelizzon
Mr. David R. Pelizzon
Independent Director
Independent Director
44.38K
+25.77%
Mr. Bryan W. Hughes
Mr. Bryan W. Hughes
Independent Director
Independent Director
32.66K
+35.01%
Mr. Samuel D. Riccitelli
Mr. Samuel D. Riccitelli
Independent Director
Independent Director
31.86K
+35.90%
Ms. Marie C. Infante, J.D.
Ms. Marie C. Infante, J.D.
Independent Director
Independent Director
31.20K
+36.65%
Ms. Kelly Fischer
Ms. Kelly Fischer
Director
Director
15.78K
+72.47%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David R. Bailey
Mr. David R. Bailey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
417.16K
+28.56%
Mr. Fred L. Hite
Mr. Fred L. Hite
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
277.48K
--
Mr. Mark C. Throdahl
Mr. Mark C. Throdahl
Chairman of the Board
Chairman of the Board
201.81K
+5.67%
Mr. Joseph W. Hauser
Mr. Joseph W. Hauser
President of Trauma, Deformity and OPSB
President of Trauma, Deformity and OPSB
194.77K
--
Mr. Gregory A. Odle
Mr. Gregory A. Odle
President of Scoliosis
President of Scoliosis
187.74K
--
Mr. David R. Pelizzon
Mr. David R. Pelizzon
Independent Director
Independent Director
44.38K
+25.77%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de OrthoPediatrics Corp?
Los cinco principales accionistas de OrthoPediatrics Corp son: Mr. David R. Bailey
¿Cuántas instituciones poseen acciones de OrthoPediatrics Corp (KIDS)?
A fecha de 2026Q1, 287 instituciones poseen acciones de OrthoPediatrics Corp, con un valor de mercado combinado de aproximadamente 18.35M, lo que representa el 71.44% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -360870.00.
¿Cuál es la mayor fuente de ganancias de OrthoPediatrics Corp?
El 2026Q1, el segmento empresarial Trauma and Deformity generó la ganancia más alta para OrthoPediatrics Corp, ascendiendo a 166.30M y representando el 70.36% de la ganancia total.